Pharmacy
News
FDA grants priority review for MM drug
Photo courtesy of Janssen The US Food and Drug Administration (FDA) has granted priority review for part of a supplemental biologics license...
News
Drug granted conditional approval to treat CLL in Canada
of venetoclax (Venclexta) Photo courtesy of AbbVie Health Canada has issued a Notice of Compliance with Conditions (NOC/c) for the BCL-2...
News
Factor IX therapy approved in Australia
The Australian Therapeutic Goods Administration has approved albutrepenonacog alfa (Idelvion) to treat hemophilia B patients of all ages....
News
Medicare doesn’t lower TKI costs enough, study suggests
cut in half with a pill splitter Photo by Patrick Pelletier Significant out-of-pocket costs may delay treatment for Medicare beneficiaries with...
News
Factor IX therapy approved in Japan
Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved albutrepenonacog alfa (Idelvion) to treat and prevent bleeding in children and...
News
Ponatinib approved to treat CML, ALL in Japan
Image from UCSD The Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has approved 2 uses of the tyrosine kinase inhibitor (TKI)...
News
Combo disappoints in newly diagnosed MM
Top-line results from the phase 3 CLARION trial suggest that treatment with carfilzomib, melphalan, and prednisone (KMP) is not superior to...
News
Malaria vaccine receives fast track designation
Image by Ute Frevert and Margaret Shear The US Food and Drug Administration (FDA) has granted fast track designation to an investigational...
News
EMA says plasma/urine-derived meds are safe from Zika
Photo by Cristina Granados Patients who take plasma-derived or urine-derived medicines do not have to worry about these products being...
News
Team creates method for predicting drug toxicity
for a clinical trial Photo by Esther Dyson Researchers have devised a method for predicting whether experimental drugs will fail clinical trials...
News
CHMP recommends approval of ixazomib for MM
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that ixazomib (NinlaroTM) receive...